Date: June 03, 2026
Regulatory Action Disclosure
Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has received a suspension order for a Drug License from the Assistant Director, Drugs Control Administration, Warangal, Telangana.
Details of Regulatory Action
Authority: Assistant Director, Drugs Control Administration, Warangal, Telangana
Nature of Action: Suspension of Drug License for one day for a store situated at Janagon Alladi complex, Telangana
Date of Order Receipt: June 02, 2026
Alleged Violation: Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules
Financial Impact: Potential revenue loss of ₹0.80 lakhs (quantifiable monetary impact)
Availability of Information
The complete details will be available on:
- Company website: www.medplusindia.com
- BSE Limited website: www.bseindia.com
- National Stock Exchange of India Ltd. website: www.nseindia.com
Not Specified: Financial Results, Dividend Declaration, KMP Changes, Board Meeting Outcomes, Auditor's Report, Disinvestment/Strategic Actions, Media Release/Investor Communication